Prosecution Insights
Last updated: November 04, 2026

Phitonex Inc.

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Phitonex Inc. is active in the Biotechnology & Pharmaceuticals technology area with 2 pending office actions. These 2 pending office actions are distributed across 2 distinct art units, which suggests that the company's current patent applications involve different technical sub-specialties. Practitioners must be prepared to navigate the different examination cultures and procedural requirements of the 2 distinct art units. The success of the 2 pending office actions depends on addressing the specific technical standards and precedents prevalent in each of these units.

The prosecution effort involves 2 distinct examiners, meaning that each pending matter is reviewed by a different official. LU, FRANK WEI MIN is the busiest examiner for the portfolio and is responsible for 1 pending office action. With 2 distinct examiners managing the 2 pending office actions, there is no centralization of the examination process at the individual level. This fragmentation requires practitioners to tailor their advocacy to the specific preferences of LU, FRANK WEI MIN and the other assigned examiner. Effectively managing the 2 pending office actions requires a high degree of coordination across the 2 distinct art units to resolve the 1 pending office action assigned to the busiest examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
0
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PHAM, KHAI QUYNH TIEN 1 0.0% +0.0%
LU, FRANK WEI MIN 1 62.4% +67.8%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18254135 Method And Composition For Multiplexed And Multimodal Single Cell Analysis PHAM, KHAI QUYNH TIEN —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18254141 Methods Of Signal Amplification LU, FRANK WEI MIN 34d

Top Art Units

Art UnitApps
1684 1
1683 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18254135 Method And Composition For Multiplexed And Multimodal Single Cell Analysis PHAM, KHAI QUYNH TIEN 1684 §102§103 Final Rejection — Pending May 23, 2023
18254141 Methods Of Signal Amplification LU, FRANK WEI MIN 1683 §103 Final Rejection 34d Pending May 23, 2023

Managing Phitonex Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Phitonex Inc. have?

Phitonex Inc. has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Phitonex Inc. applications?

Khai Quynh Tien Pham has the most, with 1 of Phitonex Inc.'s pending office actions.

What technology area are Phitonex Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month